date,title,url
2014-07-05,莎普爱思股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2014-07-04/603168_20140705_1.pdf
2014-07-05,莎普爱思：关于浙江莎普爱思药业股份有限公司股票交易异常波动的征询函的回函,/disclosure/listedinfo/announcement/c/2014-07-04/603168_20140705_2.pdf
2014-07-08,莎普爱思关于签订募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2014-07-07/603168_20140708_1.pdf
2014-07-10,莎普爱思股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2014-07-09/603168_20140710_1.pdf
2014-07-10,莎普爱思：关于浙江莎普爱思药业股份有限公司股票交易异常波动的征询函的回函,/disclosure/listedinfo/announcement/c/2014-07-09/603168_20140710_2.pdf
2014-07-15,莎普爱思股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2014-07-14/603168_20140715_1.pdf
2014-07-15,莎普爱思：关于浙江莎普爱思药业股份有限公司股票交易异常波动的征询函的回函,/disclosure/listedinfo/announcement/c/2014-07-14/603168_20140715_2.pdf
2014-08-27,莎普爱思关于召开2014年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2014-08-26/603168_20140827_8.pdf
2014-08-27,莎普爱思关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2014-08-26/603168_20140827_4.pdf
2014-08-27,莎普爱思关于使用银行承兑汇票支付募集资金投资项目所需资金并以募集资金等额置换的公告,/disclosure/listedinfo/announcement/c/2014-08-26/603168_20140827_5.pdf
2014-08-27,莎普爱思关于使用闲置自有资金投资银行低风险理财产品的公告,/disclosure/listedinfo/announcement/c/2014-08-26/603168_20140827_6.pdf
2014-08-27,莎普爱思关于使用募集资金置换预先已投入募投项目的自筹资金的公告,/disclosure/listedinfo/announcement/c/2014-08-26/603168_20140827_7.pdf
2014-08-27,莎普爱思股东大会议事规则,/disclosure/listedinfo/announcement/c/2014-08-26/603168_20140827_15.pdf
2014-08-27,莎普爱思公司章程（2014修订）,/disclosure/listedinfo/announcement/c/2014-08-26/603168_20140827_16.pdf
2014-08-27,莎普爱思独立董事关于第二届董事会第十八次会议审议有关事项的独立意见,/disclosure/listedinfo/announcement/c/2014-08-26/603168_20140827_10.pdf
2014-08-27,莎普爱思第二届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2014-08-26/603168_20140827_3.pdf
2014-08-27,莎普爱思第二届董事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2014-08-26/603168_20140827_2.pdf
2014-08-27,莎普爱思半年报摘要,/disclosure/listedinfo/announcement/c/2014-08-26/603168_2014_zzy.pdf
2014-08-27,莎普爱思半年报,/disclosure/listedinfo/announcement/c/2014-08-26/603168_2014_z.pdf
2014-08-27,莎普爱思：天健会计师事务所（特殊普通合伙）关于浙江莎普爱思药业股份有限公司以自筹资金预先投入募投项目的鉴证报告,/disclosure/listedinfo/announcement/c/2014-08-26/603168_20140827_12.pdf
2014-08-27,莎普爱思：华龙证券有限责任公司关于浙江莎普爱思药业股份有限公司使用银行承兑汇票支付募集资金投资项目所需资金并以募集资金等额置换事项的专项意见,/disclosure/listedinfo/announcement/c/2014-08-26/603168_20140827_14.pdf
2014-08-27,莎普爱思：华龙证券有限责任公司关于浙江莎普爱思药业股份有限公司使用募集资金置换预先已投入募投项目的自筹资金的专项意见,/disclosure/listedinfo/announcement/c/2014-08-26/603168_20140827_13.pdf
2014-09-03,莎普爱思委托理财公告,/disclosure/listedinfo/announcement/c/2014-09-02/603168_20140903_1.pdf
2014-09-03,莎普爱思2014年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-09-03/603168_20140903_2.pdf
2014-09-12,莎普爱思2014年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-09-11/603168_20140912_1.pdf
2014-09-12,莎普爱思2014年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-09-11/603168_20140912_2.pdf
2014-09-23,莎普爱思关于注册资本等事项完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2014-09-22/603168_20140923_1.pdf
2014-10-28,莎普爱思关于公司新厂区食堂发生爆炸事件的公告,/disclosure/listedinfo/announcement/c/2014-10-27/603168_20141028_3.pdf
2014-10-28,莎普爱思第三季度季报,/disclosure/listedinfo/announcement/c/2014-10-27/603168_2014_3.pdf
2014-12-13,莎普爱思关于股东部分股权质押的公告,/disclosure/listedinfo/announcement/c/2014-12-12/603168_20141213_1.pdf
2014-12-17,莎普爱思关于全资子公司购买资产的公告,/disclosure/listedinfo/announcement/c/2014-12-16/603168_20141217_3.pdf
2014-12-17,莎普爱思关于对全资子公司增资的公告,/disclosure/listedinfo/announcement/c/2014-12-16/603168_20141217_2.pdf
2014-12-17,莎普爱思独立董事关于全资子公司购买资产的独立意见,/disclosure/listedinfo/announcement/c/2014-12-16/603168_20141217_4.pdf
2014-12-17,莎普爱思第二届董事会第二十次会议决议公告,/disclosure/listedinfo/announcement/c/2014-12-16/603168_20141217_1.pdf
2014-12-19,莎普爱思关于第二届董事会、监事会延期换届的提示性公告,/disclosure/listedinfo/announcement/c/2014-12-18/603168_20141219_1.pdf
2014-12-20,莎普爱思关于全资子公司增资完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2014-12-19/603168_20141220_1.pdf
2014-12-31,莎普爱思关于签订投资意向书的公告,/disclosure/listedinfo/announcement/c/2014-12-30/603168_20141231_1.pdf
2015-01-09,莎普爱思：华龙证券有限责任公司关于浙江莎普爱思药业股份有限公司持续督导期间定期现场检查报告,/disclosure/listedinfo/announcement/c/2015-01-08/603168_20150109_1.pdf
2015-01-20,莎普爱思关于2014年度利润分配及资本公积金转增股本预案的预披露公告,/disclosure/listedinfo/announcement/c/2015-01-19/603168_20150120_1.pdf
2015-01-21,莎普爱思关于全资子公司购买资产进展的公告,/disclosure/listedinfo/announcement/c/2015-01-20/603168_20150121_1.pdf
2015-01-21,莎普爱思股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-01-20/603168_20150121_2.pdf
2015-01-21,莎普爱思：陈德康关于浙江莎普爱思药业股份有限公司股票交易异常波动的征询函的回函,/disclosure/listedinfo/announcement/c/2015-01-20/603168_20150121_3.pdf
2015-02-11,莎普爱思关于通过高新技术企业重新认定的公告,/disclosure/listedinfo/announcement/c/2015-02-10/603168_20150211_1.pdf
2015-02-13,莎普爱思2014年度业绩快报公告,/disclosure/listedinfo/announcement/c/2015-02-12/603168_20150213_1.pdf
2015-02-17,莎普爱思关于获得保健食品生产许可证的公告,/disclosure/listedinfo/announcement/c/2015-02-16/603168_20150217_1.pdf
2015-03-03,莎普爱思委托理财进展公告,/disclosure/listedinfo/announcement/c/2015-03-02/603168_20150303_1.pdf
2015-04-17,莎普爱思年报摘要,/disclosure/listedinfo/announcement/c/2015-04-16/603168_2014_nzy.pdf
2015-04-17,莎普爱思年报信息披露重大差错责任追究制度,/disclosure/listedinfo/announcement/c/2015-04-16/603168_20150417_20.pdf
2015-04-17,莎普爱思年报,/disclosure/listedinfo/announcement/c/2015-04-16/603168_2014_n.pdf
2015-04-17,莎普爱思内部控制评价管理办法,/disclosure/listedinfo/announcement/c/2015-04-16/603168_20150417_19.pdf
2015-04-17,莎普爱思累积投票制实施细则,/disclosure/listedinfo/announcement/c/2015-04-16/603168_20150417_18.pdf
2015-04-17,莎普爱思关于公司2014年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2015-04-16/603168_20150417_4.pdf
2015-04-17,莎普爱思独立董事提名人声明,/disclosure/listedinfo/announcement/c/2015-04-16/603168_20150417_15.pdf
2015-04-17,莎普爱思独立董事候选人声明（王虎根、赵苏靖、濮文斌）,/disclosure/listedinfo/announcement/c/2015-04-16/603168_20150417_16.pdf
2015-04-17,莎普爱思独立董事关于公司对外担保情况的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2015-04-16/603168_20150417_6.pdf
2015-04-17,莎普爱思独立董事关于第二届董事会第二十一次会议审议有关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-04-16/603168_20150417_14.pdf
2015-04-17,莎普爱思董事会审计委员会2014年度履职情况报告,/disclosure/listedinfo/announcement/c/2015-04-16/603168_20150417_13.pdf
2015-04-17,莎普爱思董事、监事及高级管理人员薪酬管理制度,/disclosure/listedinfo/announcement/c/2015-04-16/603168_20150417_17.pdf
2015-04-17,莎普爱思第二届监事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-16/603168_20150417_3.pdf
2015-04-17,莎普爱思第二届董事会第二十一次会议决议公告,/disclosure/listedinfo/announcement/c/2015-04-16/603168_20150417_2.pdf
2015-04-17,莎普爱思：募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2015-04-16/603168_20150417_11.pdf
2015-04-17,莎普爱思：华龙证券股份有限公司关于浙江莎普爱思药业股份有限公司2014年度募集资金存放与实际使用情况的专项核查意见,/disclosure/listedinfo/announcement/c/2015-04-16/603168_20150417_12.pdf
2015-04-17,莎普爱思：非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2015-04-16/603168_20150417_8.pdf
2015-04-17,莎普爱思2014年度审计报告,/disclosure/listedinfo/announcement/c/2015-04-16/603168_20150417_7.pdf
2015-04-17,莎普爱思2014年度内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2015-04-16/603168_20150417_10.pdf
2015-04-17,莎普爱思2014年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2015-04-16/603168_20150417_9.pdf
2015-04-23,莎普爱思关于召开2014年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2015-04-22/603168_20150423_2.pdf
2015-04-23,莎普爱思：华龙证券股份有限公司关于浙江莎普爱思药业股份有限公司2014年度持续督导报告书,/disclosure/listedinfo/announcement/c/2015-04-22/603168_20150423_1.pdf
2015-04-28,莎普爱思关于举办投资者接待日活动的公告,/disclosure/listedinfo/announcement/c/2015-04-27/603168_20150428_2.pdf
2015-04-28,莎普爱思第一季度季报,/disclosure/listedinfo/announcement/c/2015-04-27/603168_2015_1.pdf
2015-05-07,莎普爱思关于全资子公司获得药品经营许可证和GSP证书的公告,/disclosure/listedinfo/announcement/c/2015-05-06/603168_20150507_1.pdf
2015-05-13,莎普爱思关于召开2014年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2015-05-12/603168_20150513_2.pdf
2015-05-13,莎普爱思2014年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-05-12/603168_20150513_1.pdf
2015-05-19,莎普爱思投资者接待日活动会议纪要,/disclosure/listedinfo/announcement/c/2015-05-18/603168_20150519_3.pdf
2015-05-19,莎普爱思关于选举公司第三届监事会职工监事的公告,/disclosure/listedinfo/announcement/c/2015-05-18/603168_20150519_2.pdf
2015-05-19,莎普爱思关于投资者接待日活动举办情况的公告,/disclosure/listedinfo/announcement/c/2015-05-18/603168_20150519_1.pdf
2015-05-21,莎普爱思关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2015-05-20/603168_20150521_4.pdf
2015-05-21,莎普爱思关于股东部分股权质押的公告,/disclosure/listedinfo/announcement/c/2015-05-20/603168_20150521_5.pdf
2015-05-21,莎普爱思公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-05-20/603168_20150521_8.pdf
2015-05-21,莎普爱思独立董事关于聘任高级管理人员的独立意见,/disclosure/listedinfo/announcement/c/2015-05-20/603168_20150521_7.pdf
2015-05-21,莎普爱思第三届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2015-05-20/603168_20150521_3.pdf
2015-05-21,莎普爱思第三届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2015-05-20/603168_20150521_2.pdf
2015-05-21,莎普爱思2014年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-05-20/603168_20150521_1.pdf
2015-05-21,莎普爱思2014年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-05-20/603168_20150521_6.pdf
2015-05-22,莎普爱思委托理财进展公告,/disclosure/listedinfo/announcement/c/2015-05-21/603168_20150522_1.pdf
2015-05-26,莎普爱思关于全资子公司完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2015-05-25/603168_20150526_1.pdf
2015-05-30,莎普爱思股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-05-29/603168_20150530_1.pdf
2015-05-30,莎普爱思：关于莎普爱思药业股份有限公司股票交易异常波动的征询函的回函,/disclosure/listedinfo/announcement/c/2015-05-29/603168_20150530_2.pdf
2015-06-03,莎普爱思2014年度利润分配及资本公积金转增股本实施公告,/disclosure/listedinfo/announcement/c/2015-06-02/603168_20150603_1.pdf
2015-06-12,莎普爱思关于签订投资意向书补充协议的公告,/disclosure/listedinfo/announcement/c/2015-06-11/603168_20150612_1.pdf
2015-06-25,莎普爱思首次公开发行限售股上市流通公告,/disclosure/listedinfo/announcement/c/2015-06-24/603168_20150625_1.pdf
2015-06-25,莎普爱思关于获得老厂区搬迁补偿进展的公告,/disclosure/listedinfo/announcement/c/2015-06-24/603168_20150625_2.pdf
2015-06-25,莎普爱思：华龙证券股份有限公司关于浙江莎普爱思药业股份有限公司限售股份上市流通的核查意见,/disclosure/listedinfo/announcement/c/2015-06-24/603168_20150625_3.pdf
2015-07-04,莎普爱思股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-07-03/603168_20150704_1.pdf
2015-07-04,莎普爱思：关于浙江莎普爱思药业股份有限公司股票交易异常波动的征询函的回函,/disclosure/listedinfo/announcement/c/2015-07-03/603168_20150704_2.pdf
2015-07-11,莎普爱思关于注册资本完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2015-07-10/603168_20150711_1.pdf
2015-07-15,莎普爱思关于维护公司股价稳定的公告,/disclosure/listedinfo/announcement/c/2015-07-14/603168_20150715_1.pdf
2015-08-22,莎普爱思关于使用银行承兑汇票支付募集资金投资项目所需资金并以募集资金等额置换的公告,/disclosure/listedinfo/announcement/c/2015-08-22/603168_20150822_5.pdf
2015-08-22,莎普爱思关于使用闲置自有资金投资银行低风险理财产品的公告,/disclosure/listedinfo/announcement/c/2015-08-22/603168_20150822_6.pdf
2015-08-22,莎普爱思关于公司2015年半年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2015-08-22/603168_20150822_4.pdf
2015-08-22,莎普爱思独立董事关于第三届董事会第二次会议审议有关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-08-22/603168_20150822_9.pdf
2015-08-22,莎普爱思第三届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2015-08-22/603168_20150822_3.pdf
2015-08-22,莎普爱思第三届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2015-08-22/603168_20150822_2.pdf
2015-08-22,莎普爱思半年报摘要,/disclosure/listedinfo/announcement/c/2015-08-22/603168_2015_zzy.pdf
2015-08-22,莎普爱思半年报,/disclosure/listedinfo/announcement/c/2015-08-22/603168_2015_z.pdf
2015-08-22,莎普爱思：华龙证券股份有限公司关于浙江莎普爱思药业股份有限公司使用银行承兑汇票支付募集资金投资项目所需资金并以募集资金等额置换事项的专项意见,/disclosure/listedinfo/announcement/c/2015-08-22/603168_20150822_8.pdf
2015-08-26,莎普爱思关于股东部分股权质押的公告,/disclosure/listedinfo/announcement/c/2015-08-26/603168_20150826_1.pdf
2015-09-03,莎普爱思股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-09-03/603168_20150903_1.pdf
2015-09-03,莎普爱思：控股股东及实际控制人关于莎普爱思药业股份有限公司股票交易异常波动的征询函的回函,/disclosure/listedinfo/announcement/c/2015-09-03/603168_20150903_2.pdf
2015-10-17,莎普爱思重大事项停牌公告,/disclosure/listedinfo/announcement/c/2015-10-17/603168_20151017_1.pdf
2015-10-24,莎普爱思关于筹划非公开发行股票停牌公告,/disclosure/listedinfo/announcement/c/2015-10-24/603168_20151024_1.pdf
2015-10-28,莎普爱思第三季度季报,/disclosure/listedinfo/announcement/c/2015-10-28/603168_2015_3.pdf
2015-10-29,莎普爱思委托理财公告,/disclosure/listedinfo/announcement/c/2015-10-29/603168_20151029_1.pdf
2015-10-31,莎普爱思关于筹划非公开发行股票进展暨延期复牌公告,/disclosure/listedinfo/announcement/c/2015-10-31/603168_20151031_1.pdf
2015-11-05,莎普爱思关于股东部分股权解除质押及再质押公告,/disclosure/listedinfo/announcement/c/2015-11-05/603168_20151105_1.pdf
2015-11-07,莎普爱思关于筹划非公开发行股票进展暨第二次延期复牌公告,/disclosure/listedinfo/announcement/c/2015-11-07/603168_20151107_1.pdf
2015-11-13,莎普爱思前次募集资金使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2015-11-13/603168_20151113_11.pdf
2015-11-13,莎普爱思前次募集资金使用情况报告,/disclosure/listedinfo/announcement/c/2015-11-13/603168_20151113_1.pdf
2015-11-13,莎普爱思拟进行股权收购涉及的吉林强身药业有限责任公司股东全部权益价值评估项目资产评估报告,/disclosure/listedinfo/announcement/c/2015-11-13/603168_20151113_13.pdf
2015-11-13,莎普爱思关于召开2015年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-11-13/603168_20151113_9.pdf
2015-11-13,莎普爱思关于关联方认购非公开发行股票暨与关联方签订股份认购协议的关联事项的公告,/disclosure/listedinfo/announcement/c/2015-11-13/603168_20151113_2.pdf
2015-11-13,莎普爱思关于公司与其他认购对象签订附生效条件的股票认购协议的公告,/disclosure/listedinfo/announcement/c/2015-11-13/603168_20151113_6.pdf
2015-11-13,莎普爱思关于公司与交易对方签订附生效条件的股权转让协议的公告,/disclosure/listedinfo/announcement/c/2015-11-13/603168_20151113_7.pdf
2015-11-13,莎普爱思关于公司向银行申请并购贷款并由控股股东提供担保暨关联交易的公告,/disclosure/listedinfo/announcement/c/2015-11-13/603168_20151113_8.pdf
2015-11-13,莎普爱思关于非公开发行股票募集资金运用的可行性研究报告,/disclosure/listedinfo/announcement/c/2015-11-13/603168_20151113_10.pdf
2015-11-13,莎普爱思关于筹划非公开发行股票事项复牌的提示性公告,/disclosure/listedinfo/announcement/c/2015-11-13/603168_20151113_16.pdf
2015-11-13,莎普爱思独立董事关于第三届董事会第五次会议（临时会议）审议有关事项的事前认可意见,/disclosure/listedinfo/announcement/c/2015-11-13/603168_20151113_14.pdf
2015-11-13,莎普爱思独立董事关于第三届董事会第五次会议（临时会议）审议有关事项的独立意见,/disclosure/listedinfo/announcement/c/2015-11-13/603168_20151113_15.pdf
2015-11-13,莎普爱思第三届监事会第四次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-11-13/603168_20151113_4.pdf
2015-11-13,莎普爱思第三届董事会第五次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2015-11-13/603168_20151113_3.pdf
2015-11-13,莎普爱思：吉林强身药业有限责任公司审计报告,/disclosure/listedinfo/announcement/c/2015-11-13/603168_20151113_12.pdf
2015-11-13,莎普爱思2015年非公开发行股票预案,/disclosure/listedinfo/announcement/c/2015-11-13/603168_20151113_5.pdf
2015-11-17,莎普爱思股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2015-11-17/603168_20151117_1.pdf
2015-11-17,莎普爱思：控股股东及实际控制人关于莎普爱思股票交易异常波动的征询函的回函,/disclosure/listedinfo/announcement/c/2015-11-17/603168_20151117_2.pdf
2015-11-24,莎普爱思关于召开2015年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2015-11-24/603168_20151124_1.pdf
2015-11-24,莎普爱思2015年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-11-24/603168_20151124_2.pdf
2015-11-26,莎普爱思关于公司办公地址和投资者联系方式变更的公告,/disclosure/listedinfo/announcement/c/2015-11-26/603168_20151126_1.pdf
2015-12-02,莎普爱思2015年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-12-02/603168_20151202_1.pdf
2015-12-02,莎普爱思2015年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-12-02/603168_20151202_2.pdf
2015-12-04,莎普爱思委托理财进展公告,/disclosure/listedinfo/announcement/c/2015-12-04/603168_20151204_1.pdf
2015-12-11,莎普爱思关于获得老厂区搬迁补偿进展的公告,/disclosure/listedinfo/announcement/c/2015-12-11/603168_20151211_1.pdf
2015-12-17,莎普爱思关于全资子公司莎普爱思强身药业有限公司完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2015-12-17/603168_20151217_1.pdf
2015-12-22,莎普爱思关于控股股东部分股权质押公告,/disclosure/listedinfo/announcement/c/2015-12-22/603168_20151222_1.pdf
2016-01-08,莎普爱思关于通过药品GMP认证的提示性公告,/disclosure/listedinfo/announcement/c/2016-01-08/603168_20160108_1.pdf
2016-01-08,莎普爱思关于获得《药品GMP证书》的公告,/disclosure/listedinfo/announcement/c/2016-01-08/603168_20160108_2.pdf
2016-01-15,莎普爱思：华龙证券股份有限公司关于浙江莎普爱思药业股份有限公司持续督导期间定期现场检查报告,/disclosure/listedinfo/announcement/c/2016-01-15/603168_20160115_1.pdf
2016-01-20,莎普爱思关于持股5%以上股东减持股份计划公告,/disclosure/listedinfo/announcement/c/2016-01-20/603168_20160120_1.pdf
2016-01-27,莎普爱思关于获得《药品GMP证书》的公告,/disclosure/listedinfo/announcement/c/2016-01-27/603168_20160127_1.pdf
2016-02-24,莎普爱思关于持股5%以上股东减持股份计划实施情况公告,/disclosure/listedinfo/announcement/c/2016-02-24/603168_20160224_1.pdf
2016-03-31,莎普爱思年报摘要,/disclosure/listedinfo/announcement/c/2016-03-31/603168_2015_nzy.pdf
2016-03-31,莎普爱思年报,/disclosure/listedinfo/announcement/c/2016-03-31/603168_2015_n.pdf
2016-03-31,莎普爱思内部控制审计报告,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_17.pdf
2016-03-31,莎普爱思募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_16.pdf
2016-03-31,莎普爱思关于召开2015年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_9.pdf
2016-03-31,莎普爱思关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_5.pdf
2016-03-31,莎普爱思关于控股股东及实际控制人、董事和高级管理人员对非公开发行股票摊薄即期回报采取填补措施的承诺的公告,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_8.pdf
2016-03-31,莎普爱思关于将营销网络建设项目之结余募集资金永久补充流动资金的公告,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_6.pdf
2016-03-31,莎普爱思关于公司2015年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_4.pdf
2016-03-31,莎普爱思关于非公开发行股票摊薄即期回报及采取填补措施的公告,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_7.pdf
2016-03-31,莎普爱思公司章程（2016修订）,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_22.pdf
2016-03-31,莎普爱思非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_13.pdf
2016-03-31,莎普爱思独立董事关于公司对外担保情况的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_11.pdf
2016-03-31,莎普爱思独立董事关于第三届董事会第六次会议审议有关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_21.pdf
2016-03-31,莎普爱思董事会审计委员会2015年度履职情况报告,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_19.pdf
2016-03-31,莎普爱思第三届监事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_3.pdf
2016-03-31,莎普爱思第三届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_2.pdf
2016-03-31,莎普爱思：华龙证券股份有限公司关于浙江莎普爱思药业股份有限公司将营销网络建设项目之结余募集资金永久补充流动资金的专项意见,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_23.pdf
2016-03-31,莎普爱思：华龙证券股份有限公司关于浙江莎普爱思药业股份有限公司2015年度募集资金存放与实际使用情况的专项核查意见,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_18.pdf
2016-03-31,莎普爱思：华龙证券股份有限公司关于浙江莎普爱思药业股份有限公司2015年度持续督导报告书,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_20.pdf
2016-03-31,莎普爱思2015年度审计报告,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_12.pdf
2016-03-31,莎普爱思2015年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_15.pdf
2016-03-31,莎普爱思2015年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2016-03-31/603168_20160331_14.pdf
2016-04-12,莎普爱思关于召开2015年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-04-12/603168_20160412_1.pdf
2016-04-12,莎普爱思关于提出撤回头孢克肟颗粒补充申请的公告,/disclosure/listedinfo/announcement/c/2016-04-12/603168_20160412_2.pdf
2016-04-12,莎普爱思关于举办投资者接待日活动的公告,/disclosure/listedinfo/announcement/c/2016-04-12/603168_20160412_3.pdf
2016-04-12,莎普爱思2015年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-04-12/603168_20160412_4.pdf
2016-04-19,莎普爱思前次募集资金使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2016-04-19/603168_20160419_4.pdf
2016-04-19,莎普爱思前次募集资金使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-04-19/603168_20160419_3.pdf
2016-04-19,莎普爱思独立董事关于公司前次募集资金使用情况报告的独立意见,/disclosure/listedinfo/announcement/c/2016-04-19/603168_20160419_5.pdf
2016-04-19,莎普爱思第三届监事会第六次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-04-19/603168_20160419_2.pdf
2016-04-19,莎普爱思第三届董事会第七次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-04-19/603168_20160419_1.pdf
2016-04-21,莎普爱思投资者接待日活动会议纪要,/disclosure/listedinfo/announcement/c/2016-04-21/603168_20160421_5.pdf
2016-04-21,莎普爱思关于投资者接待日活动举办情况的公告,/disclosure/listedinfo/announcement/c/2016-04-21/603168_20160421_1.pdf
2016-04-21,莎普爱思关于获得老厂区搬迁补偿进展的公告,/disclosure/listedinfo/announcement/c/2016-04-21/603168_20160421_4.pdf
2016-04-21,莎普爱思关于公司董事、高级管理人员减持股份计划公告,/disclosure/listedinfo/announcement/c/2016-04-21/603168_20160421_3.pdf
2016-04-21,莎普爱思2015年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-04-21/603168_20160421_2.pdf
2016-04-21,莎普爱思2015年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-04-21/603168_20160421_6.pdf
2016-04-26,莎普爱思2016年第一季度报告,/disclosure/listedinfo/announcement/c/2016-04-26/603168_2016_1.pdf
2016-04-29,莎普爱思关于注册地址等事项完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2016-04-29/603168_20160429_1.pdf
2016-05-05,莎普爱思关于公司董事、高级管理人员减持股份计划实施情况公告,/disclosure/listedinfo/announcement/c/2016-05-05/603168_20160505_1.pdf
2016-05-05,莎普爱思关于非公开发行股票申请获得中国证监会受理的公告,/disclosure/listedinfo/announcement/c/2016-05-05/603168_20160505_2.pdf
2016-05-06,莎普爱思关于变更保荐机构及保荐代表人的公告,/disclosure/listedinfo/announcement/c/2016-05-06/603168_20160506_2.pdf
2016-05-06,莎普爱思2015年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2016-05-06/603168_20160506_1.pdf
2016-05-07,莎普爱思关于持股5%以上股东减持股份计划公告,/disclosure/listedinfo/announcement/c/2016-05-07/603168_20160507_1.pdf
2016-05-10,莎普爱思：华龙证券股份有限公司关于浙江莎普爱思药业股份有限公司首次公开发行股票的保荐总结报告书,/disclosure/listedinfo/announcement/c/2016-05-10/603168_20160510_1.pdf
2016-05-20,莎普爱思关于股东部分股权解除质押及再质押公告,/disclosure/listedinfo/announcement/c/2016-05-20/603168_20160520_1.pdf
2016-05-21,莎普爱思关于收到《中国证监会行政许可项目审查反馈意见通知书》的公告,/disclosure/listedinfo/announcement/c/2016-05-21/603168_20160521_1.pdf
2016-06-14,莎普爱思关于申请延期回复非公开发行股票反馈意见的公告,/disclosure/listedinfo/announcement/c/2016-06-14/603168_20160614_1.pdf
2016-07-11,莎普爱思关于与特定认购对象签署附生效条件的股份认购协议之补充协议及解除协议的公告,/disclosure/listedinfo/announcement/c/2016-07-11/603168_20160711_5.pdf
2016-07-11,莎普爱思关于实施2015年度利润分配方案后调整非公开发行股票发行价格和发行数量的公告,/disclosure/listedinfo/announcement/c/2016-07-11/603168_20160711_4.pdf
2016-07-11,莎普爱思关于非公开发行股票摊薄即期回报及采取填补措施（修订稿）的公告,/disclosure/listedinfo/announcement/c/2016-07-11/603168_20160711_7.pdf
2016-07-11,莎普爱思关于非公开发行股票涉及关联交易的公告,/disclosure/listedinfo/announcement/c/2016-07-11/603168_20160711_8.pdf
2016-07-11,莎普爱思关于非公开发行股票募集资金运用的可行性研究报告（修订稿）,/disclosure/listedinfo/announcement/c/2016-07-11/603168_20160711_11.pdf
2016-07-11,莎普爱思关于调整公司2015年非公开发行股票方案中相关事项的公告,/disclosure/listedinfo/announcement/c/2016-07-11/603168_20160711_3.pdf
2016-07-11,莎普爱思关于2015年非公开发行股票预案（修订稿）披露的提示性公告,/disclosure/listedinfo/announcement/c/2016-07-11/603168_20160711_6.pdf
2016-07-11,莎普爱思独立董事关于第三届董事会第九次会议（临时会议）审议有关事项的事前认可意见,/disclosure/listedinfo/announcement/c/2016-07-11/603168_20160711_9.pdf
2016-07-11,莎普爱思独立董事关于第三届董事会第九次会议（临时会议）审议有关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-07-11/603168_20160711_10.pdf
2016-07-11,莎普爱思第三届监事会第八次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-07-11/603168_20160711_2.pdf
2016-07-11,莎普爱思第三届董事会第九次会议（临时会议）决议公告,/disclosure/listedinfo/announcement/c/2016-07-11/603168_20160711_1.pdf
2016-07-11,莎普爱思2015年非公开发行股票预案（修订稿）,/disclosure/listedinfo/announcement/c/2016-07-11/603168_20160711_12.pdf
2016-07-15,莎普爱思关于最近五年被证券监管部门和交易所采取处罚或监管措施的情况的公告,/disclosure/listedinfo/announcement/c/2016-07-15/603168_20160715_3.pdf
2016-07-15,莎普爱思关于非公开发行股票相关承诺事项的公告,/disclosure/listedinfo/announcement/c/2016-07-15/603168_20160715_2.pdf
2016-07-15,莎普爱思关于非公开发行股票申请文件反馈意见回复的公告,/disclosure/listedinfo/announcement/c/2016-07-15/603168_20160715_1.pdf
2016-07-15,莎普爱思非公开发行股票申请文件反馈意见的回复,/disclosure/listedinfo/announcement/c/2016-07-15/603168_20160715_4.pdf
2016-07-15,莎普爱思：平安资产鑫享7号资产管理产品资产管理合同,/disclosure/listedinfo/announcement/c/2016-07-15/603168_20160715_5.pdf
2016-07-20,莎普爱思关于变更保荐机构后重新签订募集资金三方监管协议的公告,/disclosure/listedinfo/announcement/c/2016-07-20/603168_20160720_1.pdf
2016-08-11,莎普爱思关于非公开发行股票申请获得中国证监会发行审核委员会审核通过的公告,/disclosure/listedinfo/announcement/c/2016-08-11/603168_20160811_1.pdf
2016-08-24,莎普爱思信息披露暂缓与豁免事务管理制度（2016年8月）,/disclosure/listedinfo/announcement/c/2016-08-24/603168_20160824_8.pdf
2016-08-24,莎普爱思关于使用闲置自有资金投资银行低风险理财产品的公告,/disclosure/listedinfo/announcement/c/2016-08-24/603168_20160824_5.pdf
2016-08-24,莎普爱思关于公司2016年半年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2016-08-24/603168_20160824_4.pdf
2016-08-24,莎普爱思独立董事关于使用闲置自有资金投资银行低风险理财产品的独立意见,/disclosure/listedinfo/announcement/c/2016-08-24/603168_20160824_6.pdf
2016-08-24,莎普爱思第三届监事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-24/603168_20160824_3.pdf
2016-08-24,莎普爱思第三届董事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-24/603168_20160824_2.pdf
2016-08-24,莎普爱思2016年半年度报告摘要,/disclosure/listedinfo/announcement/c/2016-08-24/603168_2016_zzy.pdf
2016-08-24,莎普爱思2016年半年度报告,/disclosure/listedinfo/announcement/c/2016-08-24/603168_2016_z.pdf
2016-08-25,莎普爱思关于股东部分股权解除质押公告,/disclosure/listedinfo/announcement/c/2016-08-25/603168_20160825_1.pdf
2016-08-31,莎普爱思关于股东部分股权质押公告,/disclosure/listedinfo/announcement/c/2016-08-31/603168_20160831_1.pdf
2016-09-03,莎普爱思关于股东部分股权解除质押公告,/disclosure/listedinfo/announcement/c/2016-09-03/603168_20160903_1.pdf
2016-09-03,莎普爱思关于持股5%以上股东减持股份计划公告,/disclosure/listedinfo/announcement/c/2016-09-03/603168_20160903_2.pdf
2016-09-07,莎普爱思委托理财公告,/disclosure/listedinfo/announcement/c/2016-09-07/603168_20160907_2.pdf
2016-09-07,莎普爱思关于股东部分股权质押公告,/disclosure/listedinfo/announcement/c/2016-09-07/603168_20160907_1.pdf
2016-09-19,莎普爱思关于获得《审批意见通知件》和《药物临床试验批件》的公告,/disclosure/listedinfo/announcement/c/2016-09-19/603168_20160919_1.pdf
2016-10-10,莎普爱思关于获得老厂区搬迁补偿进展的公告,/disclosure/listedinfo/announcement/c/2016-10-10/603168_20161010_1.pdf
2016-10-12,莎普爱思关于澄清公告的补充公告,/disclosure/listedinfo/announcement/c/2016-10-12/603168_20161012_2.pdf
2016-10-12,莎普爱思澄清公告,/disclosure/listedinfo/announcement/c/2016-10-12/603168_20161012_1.pdf
2016-10-15,莎普爱思2016年第三季度业绩预增公告,/disclosure/listedinfo/announcement/c/2016-10-15/603168_20161015_1.pdf
2016-10-20,莎普爱思关于苄达赖氨酸滴眼液获得《药品补充申请批件》的公告,/disclosure/listedinfo/announcement/c/2016-10-20/603168_20161020_1.pdf
2016-10-20,莎普爱思关于获得老厂区搬迁补偿进展的公告,/disclosure/listedinfo/announcement/c/2016-10-20/603168_20161020_2.pdf
2016-10-28,莎普爱思关于召开2016年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-10-28/603168_20161028_6.pdf
2016-10-28,莎普爱思关于增加使用闲置自有资金进行委托理财额度的公告,/disclosure/listedinfo/announcement/c/2016-10-28/603168_20161028_4.pdf
2016-10-28,莎普爱思关于延长2015年非公开发行股票股东大会决议和授权有效期的公告,/disclosure/listedinfo/announcement/c/2016-10-28/603168_20161028_5.pdf
2016-10-28,莎普爱思独立董事提名人声明,/disclosure/listedinfo/announcement/c/2016-10-28/603168_20161028_10.pdf
2016-10-28,莎普爱思独立董事候选人声明（徐萍平）,/disclosure/listedinfo/announcement/c/2016-10-28/603168_20161028_13.pdf
2016-10-28,莎普爱思独立董事候选人声明（潘煜双）,/disclosure/listedinfo/announcement/c/2016-10-28/603168_20161028_12.pdf
2016-10-28,莎普爱思独立董事候选人声明（董作军）,/disclosure/listedinfo/announcement/c/2016-10-28/603168_20161028_11.pdf
2016-10-28,莎普爱思独立董事关于第三届董事会第十一次会议审议有关事项的事前认可意见,/disclosure/listedinfo/announcement/c/2016-10-28/603168_20161028_9.pdf
2016-10-28,莎普爱思独立董事关于第三届董事会第十一次会议审议有关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-10-28/603168_20161028_8.pdf
2016-10-28,莎普爱思第三届监事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2016-10-28/603168_20161028_3.pdf
2016-10-28,莎普爱思第三届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-10-28/603168_20161028_2.pdf
2016-10-28,莎普爱思2016年第三季度报告,/disclosure/listedinfo/announcement/c/2016-10-28/603168_2016_3.pdf
2016-11-04,莎普爱思简式权益变动报告书,/disclosure/listedinfo/announcement/c/2016-11-04/603168_20161104_2.pdf
2016-11-04,莎普爱思关于持股5%以上股东减持股份计划实施情况暨股东权益变动的提示性公告,/disclosure/listedinfo/announcement/c/2016-11-04/603168_20161104_1.pdf
2016-11-05,莎普爱思委托理财公告,/disclosure/listedinfo/announcement/c/2016-11-05/603168_20161105_2.pdf
2016-11-05,莎普爱思关于召开2016年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-11-05/603168_20161105_1.pdf
2016-11-05,莎普爱思2016年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-11-05/603168_20161105_3.pdf
2016-11-08,莎普爱思关于获得《药品GMP证书》的公告,/disclosure/listedinfo/announcement/c/2016-11-08/603168_20161108_1.pdf
2016-11-15,莎普爱思第三届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2016-11-15/603168_20161115_2.pdf
2016-11-15,莎普爱思2016年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-11-15/603168_20161115_1.pdf
2016-11-15,莎普爱思2016年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-11-15/603168_20161115_3.pdf
2016-11-18,莎普爱思关于收到中国证监会核准非公开发行股票批文的公告,/disclosure/listedinfo/announcement/c/2016-11-18/603168_20161118_1.pdf
2016-12-03,莎普爱思关于控股股东部分股权质押公告,/disclosure/listedinfo/announcement/c/2016-12-03/603168_20161203_1.pdf
2016-12-17,莎普爱思简式权益变动报告书,/disclosure/listedinfo/announcement/c/2016-12-17/603168_20161217_7.pdf
2016-12-17,莎普爱思关于持股5%以上股东权益变动的提示性公告,/disclosure/listedinfo/announcement/c/2016-12-17/603168_20161217_2.pdf
2016-12-17,莎普爱思非公开发行股票发行情况报告书,/disclosure/listedinfo/announcement/c/2016-12-17/603168_20161217_5.pdf
2016-12-17,莎普爱思非公开发行股票发行结果暨股本变动公告,/disclosure/listedinfo/announcement/c/2016-12-17/603168_20161217_1.pdf
2016-12-17,莎普爱思：验资报告,/disclosure/listedinfo/announcement/c/2016-12-17/603168_20161217_3.pdf
2016-12-17,莎普爱思：通力律师事务所关于浙江莎普爱思药业股份有限公司非公开发行A股股票发行过程和认购对象合规性的法律意见书,/disclosure/listedinfo/announcement/c/2016-12-17/603168_20161217_4.pdf
2016-12-17,莎普爱思：国泰君安证券股份有限公司关于浙江莎普爱思药业股份有限公司非公开发行股票发行合规性之审核报告,/disclosure/listedinfo/announcement/c/2016-12-17/603168_20161217_6.pdf
2016-12-23,莎普爱思关于获得《审批意见通知件》的公告,/disclosure/listedinfo/announcement/c/2016-12-23/603168_20161223_1.pdf
2016-12-26,莎普爱思关于签订募集资金专户存储三方及四方监管协议的公告,/disclosure/listedinfo/announcement/c/2016-12-26/603168_20161226_1.pdf
2016-12-27,莎普爱思关于终止部分募集资金投资项目并将节余募集资金永久补充流动资金的公告,/disclosure/listedinfo/announcement/c/2016-12-27/603168_20161227_6.pdf
2016-12-27,莎普爱思关于召开2017年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-12-27/603168_20161227_8.pdf
2016-12-27,莎普爱思关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2016-12-27/603168_20161227_4.pdf
2016-12-27,莎普爱思关于使用募集资金向全资子公司莎普爱思强身药业有限公司增资的公告,/disclosure/listedinfo/announcement/c/2016-12-27/603168_20161227_3.pdf
2016-12-27,莎普爱思关于使用非公开发行股票募集资金置换前期投入的自筹资金的公告,/disclosure/listedinfo/announcement/c/2016-12-27/603168_20161227_5.pdf
2016-12-27,莎普爱思关于部分募集资金投资项目调整实施内容和延期的公告,/disclosure/listedinfo/announcement/c/2016-12-27/603168_20161227_7.pdf
2016-12-27,莎普爱思股东大会议事规则,/disclosure/listedinfo/announcement/c/2016-12-27/603168_20161227_13.pdf
2016-12-27,莎普爱思公司章程（2016年12月修订）,/disclosure/listedinfo/announcement/c/2016-12-27/603168_20161227_14.pdf
2016-12-27,莎普爱思独立董事关于第三届董事会第十三次会议审议有关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-12-27/603168_20161227_12.pdf
2016-12-27,莎普爱思第三届监事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-12-27/603168_20161227_2.pdf
2016-12-27,莎普爱思第三届董事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2016-12-27/603168_20161227_1.pdf
2016-12-27,莎普爱思：天健会计师事务所（特殊普通合伙）关于浙江莎普爱思药业股份有限公司以自筹资金预先投入募投项目的鉴证报告,/disclosure/listedinfo/announcement/c/2016-12-27/603168_20161227_9.pdf
2016-12-27,莎普爱思：国泰君安证券股份有限公司关于浙江莎普爱思药业股份有限公司终止部分募集资金投资项目并将节余募集资金永久补充流动资金及部分募集资金投资项目调整实施内容和延期的核查意见,/disclosure/listedinfo/announcement/c/2016-12-27/603168_20161227_10.pdf
2016-12-27,莎普爱思：国泰君安证券股份有限公司关于浙江莎普爱思药业股份有限公司使用募集资金置换预先投入募投项目自筹资金及向子公司增资的核查意见,/disclosure/listedinfo/announcement/c/2016-12-27/603168_20161227_11.pdf
2016-12-29,莎普爱思：国泰君安证券股份有限公司关于浙江莎普爱思药业股份有限公司持续督导现场检查报告,/disclosure/listedinfo/announcement/c/2016-12-29/603168_20161229_1.pdf
2016-12-31,莎普爱思关于召开2017年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-12-31/603168_20161231_2.pdf
2016-12-31,莎普爱思关于使用募集资金向全资子公司莎普爱思强身药业有限公司增资进展情况的公告,/disclosure/listedinfo/announcement/c/2016-12-31/603168_20161231_1.pdf
2016-12-31,莎普爱思2017年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-12-31/603168_20161231_3.pdf
2017-01-06,莎普爱思关于控股股东部分股权解除质押公告,/disclosure/listedinfo/announcement/c/2017-01-06/603168_20170106_1.pdf
2017-01-12,莎普爱思2017年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-01-12/603168_20170112_1.pdf
2017-01-12,莎普爱思2017年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-01-12/603168_20170112_2.pdf
2017-01-25,莎普爱思2016年年度业绩预增公告,/disclosure/listedinfo/announcement/c/2017-01-25/603168_20170125_1.pdf
2017-01-26,莎普爱思关于注册资本等事项完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2017-01-26/603168_20170126_1.pdf
2017-02-23,莎普爱思关于注销部分募集资金专户的公告,/disclosure/listedinfo/announcement/c/2017-02-23/603168_20170223_1.pdf
2017-02-25,莎普爱思关于持股5%以上股东减持股份计划公告,/disclosure/listedinfo/announcement/c/2017-02-25/603168_20170225_1.pdf
2017-02-27,莎普爱思关于获得《药品GMP证书》的公告,/disclosure/listedinfo/announcement/c/2017-02-27/603168_20170227_1.pdf
2017-03-08,莎普爱思委托理财进展公告,/disclosure/listedinfo/announcement/c/2017-03-08/603168_20170308_2.pdf
2017-03-08,莎普爱思关于持股5%以上股东减持股份计划实施情况公告,/disclosure/listedinfo/announcement/c/2017-03-08/603168_20170308_1.pdf
2017-03-10,莎普爱思关于持股5%以上股东减持股份计划公告,/disclosure/listedinfo/announcement/c/2017-03-10/603168_20170310_1.pdf
2017-03-16,莎普爱思委托理财进展公告,/disclosure/listedinfo/announcement/c/2017-03-16/603168_20170316_1.pdf
2017-03-21,莎普爱思委托理财进展公告,/disclosure/listedinfo/announcement/c/2017-03-21/603168_20170321_1.pdf
2017-04-05,莎普爱思关于获得《审批意见通知件》的公告,/disclosure/listedinfo/announcement/c/2017-04-05/603168_20170405_1.pdf
2017-04-08,莎普爱思关于获得《药物临床试验批件》的公告,/disclosure/listedinfo/announcement/c/2017-04-08/603168_20170408_1.pdf
2017-04-26,莎普爱思未来三年（2017年-2019年）股东分红回报规划,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_26.pdf
2017-04-26,莎普爱思控股子公司管理制度（2017年4月）,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_27.pdf
2017-04-26,莎普爱思关于召开2016年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_3.pdf
2017-04-26,莎普爱思关于增加使用闲置自有资金进行委托理财额度的公告,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_1.pdf
2017-04-26,莎普爱思关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_8.pdf
2017-04-26,莎普爱思关于收购强身药业100%股权所涉业绩承诺2016年度实现情况及资产转让方拟对公司进行业绩补偿的公告,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_2.pdf
2017-04-26,莎普爱思关于公司2017年度向银行申请授信额度及相关授权的公告,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_10.pdf
2017-04-26,莎普爱思关于2016年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_9.pdf
2017-04-26,莎普爱思公司章程（2017年4月修订）,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_28.pdf
2017-04-26,莎普爱思独立董事关于公司对外担保情况的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_12.pdf
2017-04-26,莎普爱思独立董事关于第三届董事会第十四次会议审议有关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_25.pdf
2017-04-26,莎普爱思董事会审计委员会2016年度履职情况报告,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_20.pdf
2017-04-26,莎普爱思第三届监事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_7.pdf
2017-04-26,莎普爱思第三届董事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_6.pdf
2017-04-26,莎普爱思：内部控制审计报告,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_18.pdf
2017-04-26,莎普爱思：募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_17.pdf
2017-04-26,莎普爱思：坤元资产评估有限公司关于浙江莎普爱思药业股份有限公司拟进行商誉减值测试涉及的莎普爱思强身药业有限公司资产组价值评估项目资产评估报告,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_29.pdf
2017-04-26,莎普爱思：国泰君安证券股份有限公司关于浙江莎普爱思药业股份有限公司收购强身药业100%股权所涉业绩承诺2016年度实现情况的核查意见,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_22.pdf
2017-04-26,莎普爱思：国泰君安证券股份有限公司关于浙江莎普爱思药业股份有限公司2016年度募集资金存放与使用情况的专项核查报告,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_19.pdf
2017-04-26,莎普爱思：国泰君安证券股份有限公司关于浙江莎普爱思药业股份有限公司2016年度持续督导报告,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_21.pdf
2017-04-26,莎普爱思：关于莎普爱思强身药业公司业绩承诺完成情况的鉴证报告,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_23.pdf
2017-04-26,莎普爱思：非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_14.pdf
2017-04-26,莎普爱思：2016年度审计报告,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_13.pdf
2017-04-26,莎普爱思2017年第一季度报告,/disclosure/listedinfo/announcement/c/2017-04-26/603168_2017_1.pdf
2017-04-26,莎普爱思2016年年度报告摘要,/disclosure/listedinfo/announcement/c/2017-04-26/603168_2016_nzy.pdf
2017-04-26,莎普爱思2016年年度报告,/disclosure/listedinfo/announcement/c/2017-04-26/603168_2016_n.pdf
2017-04-26,莎普爱思2016年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_16.pdf
2017-04-26,莎普爱思2016年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2017-04-26/603168_20170426_15.pdf
2017-04-29,莎普爱思关于举办投资者接待日活动的公告,/disclosure/listedinfo/announcement/c/2017-04-29/603168_20170429_1.pdf
2017-05-04,莎普爱思关于召开2016年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2017-05-04/603168_20170504_1.pdf
2017-05-04,莎普爱思2016年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-05-04/603168_20170504_2.pdf
2017-05-06,莎普爱思关于收到资产转让方东丰药业业绩补偿款的提示性公告,/disclosure/listedinfo/announcement/c/2017-05-06/603168_20170506_1.pdf
2017-05-11,莎普爱思委托理财公告,/disclosure/listedinfo/announcement/c/2017-05-11/603168_20170511_1.pdf
2017-05-18,莎普爱思关于投资者接待日活动举办情况的公告,/disclosure/listedinfo/announcement/c/2017-05-18/603168_20170518_1.pdf
2017-05-18,莎普爱思2016年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-05-18/603168_20170518_2.pdf
2017-05-18,莎普爱思2016年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-05-18/603168_20170518_3.pdf
2017-05-24,莎普爱思关于控股股东部分股权质押公告,/disclosure/listedinfo/announcement/c/2017-05-24/603168_20170524_1.pdf
2017-06-02,莎普爱思关于持股5%以上股东减持股份计划实施进展公告,/disclosure/listedinfo/announcement/c/2017-06-02/603168_20170602_2.pdf
2017-06-02,莎普爱思2016年年度权益分派实施公告,/disclosure/listedinfo/announcement/c/2017-06-02/603168_20170602_1.pdf
2017-06-15,莎普爱思关于股东部分股权解除质押及再质押公告,/disclosure/listedinfo/announcement/c/2017-06-15/603168_20170615_1.pdf
2017-06-27,莎普爱思首次公开发行限售股上市流通公告,/disclosure/listedinfo/announcement/c/2017-06-27/603168_20170627_1.pdf
2017-06-27,莎普爱思：国泰君安证券股份有限公司关于浙江莎普爱思药业股份有限公司首次公开发行限售股解禁上市流通之核查意见,/disclosure/listedinfo/announcement/c/2017-06-27/603168_20170627_2.pdf
2017-06-30,莎普爱思委托理财进展公告,/disclosure/listedinfo/announcement/c/2017-06-30/603168_20170630_1.pdf
2017-07-01,莎普爱思关于全资子公司购买资产取得不动产权证书公告,/disclosure/listedinfo/announcement/c/2017-07-01/603168_20170701_1.pdf
2017-07-04,莎普爱思持股5%以上股东减持股份结果公告,/disclosure/listedinfo/announcement/c/2017-07-04/603168_20170704_1.pdf
2017-07-05,莎普爱思委托理财进展公告,/disclosure/listedinfo/announcement/c/2017-07-05/603168_20170705_1.pdf
2017-07-08,莎普爱思关于注册资本完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2017-07-08/603168_20170708_1.pdf
2017-07-20,莎普爱思关于股东部分股权质押公告,/disclosure/listedinfo/announcement/c/2017-07-20/603168_20170720_1.pdf
2017-08-19,莎普爱思委托理财进展公告,/disclosure/listedinfo/announcement/c/2017-08-19/603168_20170819_8.pdf
2017-08-19,莎普爱思关于会计政策变更的公告,/disclosure/listedinfo/announcement/c/2017-08-19/603168_20170819_7.pdf
2017-08-19,莎普爱思关于2017年半年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-08-19/603168_20170819_6.pdf
2017-08-19,莎普爱思独立董事关于会计政策变更的独立意见,/disclosure/listedinfo/announcement/c/2017-08-19/603168_20170819_4.pdf
2017-08-19,莎普爱思第三届监事会第十三次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-19/603168_20170819_5.pdf
2017-08-19,莎普爱思第三届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-19/603168_20170819_3.pdf
2017-08-19,莎普爱思2017年半年度报告摘要,/disclosure/listedinfo/announcement/c/2017-08-19/603168_2017_zzy.pdf
2017-08-19,莎普爱思2017年半年度报告,/disclosure/listedinfo/announcement/c/2017-08-19/603168_2017_z.pdf
2017-08-26,莎普爱思关于持股5%以上股东减持股份计划公告,/disclosure/listedinfo/announcement/c/2017-08-26/603168_20170826_1.pdf
2017-08-31,莎普爱思关于股东部分股权解除质押公告,/disclosure/listedinfo/announcement/c/2017-08-31/603168_20170831_1.pdf
2017-09-05,莎普爱思关于股东部分股权质押公告,/disclosure/listedinfo/announcement/c/2017-09-05/603168_20170905_1.pdf
2017-09-05,莎普爱思持股5%以上股东减持股份结果公告,/disclosure/listedinfo/announcement/c/2017-09-05/603168_20170905_2.pdf
2017-09-07,莎普爱思关于股东部分股权解除质押公告,/disclosure/listedinfo/announcement/c/2017-09-07/603168_20170907_1.pdf
2017-09-19,莎普爱思关于持股5%以上股东减持股份计划公告,/disclosure/listedinfo/announcement/c/2017-09-19/603168_20170919_1.pdf
2017-09-27,莎普爱思关于全资孙公司莎普爱思大药房完成工商变更登记并取得营业执照的公告,/disclosure/listedinfo/announcement/c/2017-09-27/603168_20170927_1.pdf
2017-09-30,莎普爱思关于终止部分募投项目和调整部分募投项目总投资、实施内容、调整部分募集资金使用计划的公告,/disclosure/listedinfo/announcement/c/2017-09-30/603168_20170930_8.pdf
2017-09-30,莎普爱思关于召开2017年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-09-30/603168_20170930_13.pdf
2017-09-30,莎普爱思关于增加使用闲置自有资金进行委托理财投资范围的公告,/disclosure/listedinfo/announcement/c/2017-09-30/603168_20170930_12.pdf
2017-09-30,莎普爱思关于增加公司经营范围并修订《公司章程》相关条款的公告,/disclosure/listedinfo/announcement/c/2017-09-30/603168_20170930_10.pdf
2017-09-30,莎普爱思关于首次公开发行股票募投项目结项并将节余募集资金永久补充流动资金的公告,/disclosure/listedinfo/announcement/c/2017-09-30/603168_20170930_7.pdf
2017-09-30,莎普爱思关于使用募集资金向全资子公司莎普爱思强身药业有限公司增资的公告,/disclosure/listedinfo/announcement/c/2017-09-30/603168_20170930_9.pdf
2017-09-30,莎普爱思公司章程（2017年9月修订）,/disclosure/listedinfo/announcement/c/2017-09-30/603168_20170930_11.pdf
2017-09-30,莎普爱思独立董事关于第三届董事会第十六次会议审议有关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-09-30/603168_20170930_5.pdf
2017-09-30,莎普爱思第三届监事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-09-30/603168_20170930_6.pdf
2017-09-30,莎普爱思第三届董事会第十六次会议决议公告,/disclosure/listedinfo/announcement/c/2017-09-30/603168_20170930_1.pdf
2017-09-30,莎普爱思：国泰君安证券股份有限公司关于浙江莎普爱思药业股份有限公司终止部分募投项目和调整部分募投项目总投资、实施内容、调整部分募集资金使用计划的核查意见,/disclosure/listedinfo/announcement/c/2017-09-30/603168_20170930_3.pdf
2017-09-30,莎普爱思：国泰君安证券股份有限公司关于浙江莎普爱思药业股份有限公司首次公开发行股票募投项目结项并将节余募集资金永久补充流动资金的核查意见,/disclosure/listedinfo/announcement/c/2017-09-30/603168_20170930_2.pdf
2017-09-30,莎普爱思：国泰君安证券股份有限公司关于浙江莎普爱思药业股份有限公司使用募集资金向全资子公司增资的核查意见,/disclosure/listedinfo/announcement/c/2017-09-30/603168_20170930_4.pdf
2017-10-10,莎普爱思关于召开2017年第二次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2017-10-10/603168_20171010_1.pdf
2017-10-10,莎普爱思2017年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-10-10/603168_20171010_2.pdf
2017-10-12,莎普爱思委托理财公告,/disclosure/listedinfo/announcement/c/2017-10-12/603168_20171012_1.pdf
2017-10-17,莎普爱思委托理财公告,/disclosure/listedinfo/announcement/c/2017-10-17/603168_20171017_3.pdf
2017-10-17,莎普爱思关于独立董事辞职的公告,/disclosure/listedinfo/announcement/c/2017-10-17/603168_20171017_4.pdf
2017-10-17,莎普爱思2017年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-10-17/603168_20171017_1.pdf
2017-10-17,莎普爱思2017年第二次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2017-10-17/603168_20171017_2.pdf
2017-10-21,莎普爱思关于注销首次公开发行股票募集资金专户的公告,/disclosure/listedinfo/announcement/c/2017-10-21/603168_20171021_1.pdf
2017-10-27,莎普爱思2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-27/603168_2017_3.pdf
2017-10-28,莎普爱思关于使用募集资金向全资子公司莎普爱思强身药业有限公司增资进展情况的公告,/disclosure/listedinfo/announcement/c/2017-10-28/603168_20171028_1.pdf
2017-10-28,莎普爱思关于经营范围等事项完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2017-10-28/603168_20171028_2.pdf
2017-10-31,莎普爱思关于持股5%以上股东减持股份计划实施进展公告,/disclosure/listedinfo/announcement/c/2017-10-31/603168_20171031_1.pdf
2017-11-25,莎普爱思关于持股5%以上股东误操作导致短线交易情况公告,/disclosure/listedinfo/announcement/c/2017-11-25/603168_20171125_1.pdf
2017-11-30,莎普爱思持股5%以上股东减持股份计划实施结果公告,/disclosure/listedinfo/announcement/c/2017-11-30/603168_20171130_1.pdf
2017-12-02,莎普爱思关于持股5%以上股东减持股份计划实施进展公告,/disclosure/listedinfo/announcement/c/2017-12-02/603168_20171202_1.pdf
2017-12-04,莎普爱思关于媒体报道的澄清公告,/disclosure/listedinfo/announcement/c/2017-12-04/603168_20171204_1.pdf
2017-12-08,莎普爱思关于公司股票连续停牌的提示性公告,/disclosure/listedinfo/announcement/c/2017-12-08/603168_20171208_1.pdf
2017-12-09,莎普爱思关于收到上海证券交易所问询函和浙江证监局监管关注函的公告,/disclosure/listedinfo/announcement/c/2017-12-09/603168_20171209_1.pdf
2017-12-13,莎普爱思关于延期回复上海证券交易所问询函和浙江证监局监管关注函暨公司股票继续停牌的提示性公告,/disclosure/listedinfo/announcement/c/2017-12-13/603168_20171213_1.pdf
2017-12-14,莎普爱思委托理财进展公告,/disclosure/listedinfo/announcement/c/2017-12-14/603168_20171214_1.pdf
2017-12-16,莎普爱思关于上海证券交易所问询函和浙江证监局监管关注函回复的公告,/disclosure/listedinfo/announcement/c/2017-12-16/603168_20171216_2.pdf
2017-12-16,莎普爱思关于公司股票复牌的提示性公告,/disclosure/listedinfo/announcement/c/2017-12-16/603168_20171216_1.pdf
2017-12-16,莎普爱思：天健会计师事务所关于浙江莎普爱思药业股份有限公司关注函中有关事项的说明,/disclosure/listedinfo/announcement/c/2017-12-16/603168_20171216_3.pdf
2017-12-19,莎普爱思委托理财进展公告,/disclosure/listedinfo/announcement/c/2017-12-19/603168_20171219_1.pdf
2017-12-20,莎普爱思关于相关股东承诺不减持公司股份公告,/disclosure/listedinfo/announcement/c/2017-12-20/603168_20171220_2.pdf
2017-12-20,莎普爱思关于控股股东及实际控制人增持股份计划公告,/disclosure/listedinfo/announcement/c/2017-12-20/603168_20171220_1.pdf
2017-12-20,莎普爱思关于持股5%以上股东减持股份计划实施结果公告,/disclosure/listedinfo/announcement/c/2017-12-20/603168_20171220_3.pdf
2017-12-20,莎普爱思股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2017-12-20/603168_20171220_4.pdf
2017-12-20,莎普爱思：控股股东及实际控制人关于莎普爱思股票交易异常波动的征询函的回函,/disclosure/listedinfo/announcement/c/2017-12-20/603168_20171220_5.pdf
2017-12-21,莎普爱思关于控股股东部分股权补充质押公告,/disclosure/listedinfo/announcement/c/2017-12-21/603168_20171221_1.pdf
2017-12-22,莎普爱思关于股东部分股权补充质押公告,/disclosure/listedinfo/announcement/c/2017-12-22/603168_20171222_1.pdf
2017-12-23,莎普爱思关于通过高新技术企业重新认定的公告,/disclosure/listedinfo/announcement/c/2017-12-23/603168_20171223_1.pdf
2017-12-27,莎普爱思委托理财进展公告,/disclosure/listedinfo/announcement/c/2017-12-27/603168_20171227_1.pdf
2018-01-06,莎普爱思：国泰君安证券股份有限公司关于浙江莎普爱思药业股份有限公司持续督导现场检查报告,/disclosure/listedinfo/announcement/c/2018-01-06/603168_20180106_1.pdf
2018-01-10,莎普爱思关于控股股东及实际控制人增持股份计划进展公告,/disclosure/listedinfo/announcement/c/2018-01-10/603168_20180110_1.pdf
2018-01-13,莎普爱思委托理财公告,/disclosure/listedinfo/announcement/c/2018-01-13/603168_20180113_1.pdf
2018-01-16,莎普爱思委托理财公告,/disclosure/listedinfo/announcement/c/2018-01-16/603168_20180116_1.pdf
2018-01-17,莎普爱思关于公司收到国家知识产权局专利复审委员会审查决定书的公告,/disclosure/listedinfo/announcement/c/2018-01-17/603168_20180117_1.pdf
2018-01-19,莎普爱思委托理财公告,/disclosure/listedinfo/announcement/c/2018-01-19/603168_20180119_1.pdf
2018-02-08,莎普爱思关于控股股东部分股权补充质押公告,/disclosure/listedinfo/announcement/c/2018-02-08/603168_20180208_1.pdf
